The Effect of Exposure to Maternal Human Milk Odor on Physiological State of Preterms.
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Mammalian fetal sensory development comes in an invariant series, with the tactile/kinesthetic and chemosensory systems the earliest functioning and responsive to stimulation, implicating the importance of these foundational sensory systems for later development. Olfaction is essential for neonatal behavioral adaptation in many mammals, including humans. Experiments show that newborns recognize, and are soothed by, the smell of amniotic fluid. Provision of the mother's smell with breast pads, handkerchiefs she has worn, breast milk on a cotton ball or cotton applicator, or other means of providing odor and taste input can facilitate recognition by the infant's mother at a later time and does not appear to be detrimental to the stability of the infant.
Provision of the odor and taste of the mother's milk has been shown to facilitate the infant's mouthing, sucking, arousal, and calming from irritability, especially in preparation for oral feeding. Using 24 hour monitor analysis and cortisol saliva measurements, we will provide quantitive analysis to the effect of smell.
| Condition | Intervention |
|---|---|
|
Health Preterm Infants With no Active Disease Human Milk Nutrition Incubator Stay |
Other: adding pad with maternal milk in hte incubator |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | The Effect of Exposure to Maternal Human Milk Odor on Physiological State of Preterms. |
| Estimated Enrollment: | 20 |
| Study Start Date: | December 2009 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
20 preterm infants
20 preterm infants without active disease
|
Other: adding pad with maternal milk in hte incubator
2 days prior to intervention - recording infants data and taking saliva cortisol adding pad with maternal milk - during 2 days - recording infants data and taking saliva cortisol. stopping intervention and for other 2 days recording infants data and taking saliva cortisol |
Eligibility| Ages Eligible for Study: | up to 4 Weeks |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
preterm infants at least 1 weekk of age no active disease or treatment (like respiratory support) place in incubator
Inclusion Criteria:
- preterm infants at least 1 week of age
- no active disease or treatment (like respiratory support)
- place in incubator
Exclusion Criteria:
- active disease or treatment
Contacts and Locations| Israel | |
| Sheba medical center | Not yet recruiting |
| Ramat - Gan, Israel, 52621 | |
| Contact: Ayala Maayan-Metzger, Dr. 972-3-5302227 maayan@post.tau.ac.il | |
More Information
No publications provided
| Responsible Party: | Dr. Ayala Maayan, Sheba Medical Cener |
| ClinicalTrials.gov Identifier: | NCT01012505 History of Changes |
| Other Study ID Numbers: | SHEBA-09-7392-AM-CTIL |
| Study First Received: | November 11, 2009 |
| Last Updated: | November 12, 2009 |
| Health Authority: | Israel: Israeli Health Ministry Pharaceutical Adnisitration |
ClinicalTrials.gov processed this record on June 18, 2013